Breaking News on Pharmaceutical Technology

Granules says Big Pharma demand drove gains in Q3

24-Jan-2012 - Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.

News in brief

PolyPid to take delivery tech into trials with new funds

24-Jan-2012 - PolyPid plans to begin clinical development of its novel lipid-polymer fusion-based drug delivery technology with new through a new financing round.

Polytherics buys Warwick Effect Polymers for biodrug modification tech

23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.

Alnylam cutting headcount to focus cash on RNAi projects

23-Jan-2012 - Alnylam is cutting its headcount by one-third to lower operating costs as it attempts to bring an RNAi product to market.

EMA revises active substance guidelines to streamline regs

23-Jan-2012 - The EMA has revised guidelines on active substance master files (ASMF) to stop multiple EU nations assessing the same documents.

NovaDel seeks sale to save it from bankruptcy protection

19-Jan-2012 - Drug delivery firm NovaDel has warned it lacks the cash to continue beyond this month and may file for bankruptcy protection.

Air can be used as barrier for controlled drug release, say scientists

18-Jan-2012 - A new study has found a way to use air as a barrier for controlled drug release.

German firms partner to bring biocatalysis to fine chemicals

18-Jan-2012 - Enzymicals and Herbrand PharmaChemicals have partnered to incorporate biocatalytic processes into fine chemical manufacturing.

Sigma-Aldrich looks to HPAPIs as generic sector heats up

18-Jan-2012 - Sigma-Aldrich is prioritising HPAPIs as it seeks to grow its custom pharma business in the face of low-cost competition.

Excipact scheme to launch next week

17-Jan-2012 - Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.

UPDATE

New RNA delivery platform could improve aptamer internalisation, say researchers

16-Jan-2012 - A new discovery platform for RNA delivery vehicles could mean 20 per cent more efficiency for guiding nanoparticles into cancer cells, say researchers.

News in brief

Clinigen inks antiretroviral API production pact with PCAS

12-Jan-2012 - Clinigen and PCAS have inked a long term supply pact for the production of the API for Foscavir.

US team develops H-heterocyles production method with implications for Pharma

12-Jan-2012 - US scientists say a new N-heterocycles synthesis method could open door to the production of novel antibiotics, cancer and pain drugs.

Injectables maker NantWorks will give Pfizer's old Indiana facility an $85.5m makeover

12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.

Lack of tax transparency in '10 may put pharma off Puerto Rico

12-Jan-2012 - The lack of transparency when Puerto Rico imposed a new tax in 2010 may deter drugmakers from expanding on the island, a report found.

Amarin wants fourth omega-3 API supplier for AM101

11-Jan-2012 - Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.

Ashland to boost disintegrant capacity at Texas plant

11-Jan-2012 - Ashland says it will ramp up production of the tablet disintegrant and dissolution aid polyvinylpyrrolidone (PVPP) to meet growing drug industry demand.

Update

SkyePharma considering cuts at Muttenz; leases lab space to Aenova

10-Jan-2012 - Drug delivery tech firm SkyePharma has started reviewing operations at its facility in Muttenz, Switzerland that could results in significant job cuts.

MonoSol and Midatech form new nanoparticle-film delivery tech JV

10-Jan-2012 - Delivery tech firm MonoSol Rx and nanoparticle excipient developer Midatech have set up a new diabetes-focused joint venture (JV).

Zhongxi Sunve buys stake in Chinese oncology API business

10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.

News in brief

India to inspect six China manufacturers following GMP complaints

09-Jan-2012 - Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.

Rousselot buys Eastman Gelatine Corp in bid for pharma growth

09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.

Julphar to become first Middle Eastern insulin maker

05-Jan-2012 - Gulf Pharmaceutical Industries is set to become the first insulin maker in the Middle East with its new $136m plant in Ras Al Khaimah, UAE.

Alnylam hails RNAi delivery tech as future of biz after PhI results

05-Jan-2012 - Phase I data shows Alnylam a “very potent” RNAi delivery platform that can be the foundation of its future, the company’s CEO said.

News in brief

India trade delegation to target Latin America export growth

05-Jan-2012 - India is sending a delegation to Chile, Peru, Columbia and Venezuela to boost pharma exports to Latin America.

Sign up for your free newsletter

Supplier Webinars